Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) Cash-to-Debt : No Debt ⁽¹⁾ (As of Sep. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Macro Group Pharmaceuticals (Macro Capital) Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Macro Group Pharmaceuticals (Macro Capital) Co's cash to debt ratio for the quarter that ended in Sep. 2023 was No Debt ⁽¹⁾.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Macro Group Pharmaceuticals (Macro Capital) Co could pay off its debt using the cash in hand for the quarter that ended in Sep. 2023.

(1) Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Macro Group Pharmaceuticals (Macro Capital) Co's Cash-to-Debt or its related term are showing as below:

CAI:MCRO' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.18 Med: 0.82 Max: No Debt
Current: 0.18

During the past 3 years, Macro Group Pharmaceuticals (Macro Capital) Co's highest Cash to Debt Ratio was No Debt. The lowest was 0.18. And the median was 0.82.

CAI:MCRO's Cash-to-Debt is ranked worse than
70.76% of 1874 companies
in the Consumer Packaged Goods industry
Industry Median: 0.51 vs CAI:MCRO: 0.18

Macro Group Pharmaceuticals (Macro Capital) Co Cash-to-Debt Historical Data

The historical data trend for Macro Group Pharmaceuticals (Macro Capital) Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Macro Group Pharmaceuticals (Macro Capital) Co Cash-to-Debt Chart

Macro Group Pharmaceuticals (Macro Capital) Co Annual Data

Trend

Dec20

Dec21

Dec22

Cash-to-Debt

N/A

0.82

1.16

Macro Group Pharmaceuticals (Macro Capital) Co Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Sep23
Cash-to-Debt	Get a 7-Day Free Trial						1.10	0.54	0.45	1.16	No Debt

Competitive Comparison of Macro Group Pharmaceuticals (Macro Capital) Co's Cash-to-Debt

For the Household & Personal Products subindustry, Macro Group Pharmaceuticals (Macro Capital) Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Macro Group Pharmaceuticals (Macro Capital) Co's Cash-to-Debt Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Macro Group Pharmaceuticals (Macro Capital) Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Macro Group Pharmaceuticals (Macro Capital) Co's Cash-to-Debt falls into.

Macro Group Pharmaceuticals (Macro Capital) Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Macro Group Pharmaceuticals (Macro Capital) Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2022 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	186.752	/	(139.879	+	20.631)
	=	1.16

Macro Group Pharmaceuticals (Macro Capital) Co's Cash to Debt Ratio for the quarter that ended in Sep. 2023 is calculated as:

Macro Group Pharmaceuticals (Macro Capital) Co had no debt ⁽¹⁾.

Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Macro Group Pharmaceuticals (Macro Capital) Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Macro Group Pharmaceuticals (Macro Capital) Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

83, Al Moltaka Al Arabi, Sheraton, Cairo, EGY

Website

https://www.macro-egy.com

Macro Group Pharmaceuticals (Macro Capital) Co is principally engaged in the manufacture and sale of cosmeceutical and ventured into nutraceutical products.

Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) Cash-to-Debt : No Debt (1) (As of Sep. 2023)